Abstract
Somatic cell nuclear transfer or therapeutic cloning has provided great hope for stem cell-based therapies. However, therapeutic cloning has been experiencing both ethical and technical difficulties. Recent breakthrough studies using a combination of four factors to reprogram human somatic cells into pluripotent stem cells without using embryos or eggs have led to an important revolution in stem cell research. Comparative analysis of human induced pluripotent stem cells and human embryonic stem cells using assays for morphology, cell surface marker expression, gene expression profiling, epigenetic status, and differentiation potential have revealed a remarkable degree of similarity between these two pluripotent stem cell types. This mini-review summarizes these ground-breaking studies. These advances in reprogramming will enable the creation of patient-specific stem cell lines to study various disease mechanisms. The cellular models created will provide valuable tools for drug discovery. Furthermore, this reprogramming system provides great potential to design customized patient-specific stem cell therapies with economic feasibility.
Keywords: Reprogramming, pluripotency, embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, stem cell therapy, regenerative medicine
Current Molecular Pharmacology
Title: Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies
Volume: 2
Author(s): Yanhong Shi
Affiliation:
Keywords: Reprogramming, pluripotency, embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, stem cell therapy, regenerative medicine
Abstract: Somatic cell nuclear transfer or therapeutic cloning has provided great hope for stem cell-based therapies. However, therapeutic cloning has been experiencing both ethical and technical difficulties. Recent breakthrough studies using a combination of four factors to reprogram human somatic cells into pluripotent stem cells without using embryos or eggs have led to an important revolution in stem cell research. Comparative analysis of human induced pluripotent stem cells and human embryonic stem cells using assays for morphology, cell surface marker expression, gene expression profiling, epigenetic status, and differentiation potential have revealed a remarkable degree of similarity between these two pluripotent stem cell types. This mini-review summarizes these ground-breaking studies. These advances in reprogramming will enable the creation of patient-specific stem cell lines to study various disease mechanisms. The cellular models created will provide valuable tools for drug discovery. Furthermore, this reprogramming system provides great potential to design customized patient-specific stem cell therapies with economic feasibility.
Export Options
About this article
Cite this article as:
Shi Yanhong, Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies, Current Molecular Pharmacology 2009; 2 (1) . https://dx.doi.org/10.2174/1874467210902010015
DOI https://dx.doi.org/10.2174/1874467210902010015 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Human-Derived Organ-on-a-Chip for Personalized Drug Development
Current Pharmaceutical Design Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Clinical Relevance of Indoleamine 2,3-Dioxygenase (Guest Editor: Dietmar Fuchs) ]
Current Drug Metabolism Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents
Current Drug Delivery Editorial (Thematic Issue: Biological Function of G-Quadruplex Nucleic Acids and Potential Application in Medicinal Chemistry)
Current Topics in Medicinal Chemistry Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
Current Psychopharmacology PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Current Drug Metabolism Editorial [Hot Topic: Adrenoceptors as Targets in Drug Discovery: Medicinal Chemistry and Therapeutical Potential (Guest Editors: Professors Maria Pigini and Wilma Quaglia)]
Current Topics in Medicinal Chemistry Do Rheumatoid Arthritis Patients Rate their Health Status Different than their Caregivers?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
Current Drug Targets - Cardiovascular & Hematological Disorders Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Heterogeneity Amongst 5-HT3 Receptor Subunits: Is this Significant?
Current Molecular Medicine Abnormal Sleep Behaviours Across the Spectrum of Alzheimer’s Disease Severity: Influence of APOE Genotypes and Lewy Bodies
Current Alzheimer Research Protein Homeostasis as a Therapeutic Target for Diseases of Protein Conformation
Current Topics in Medicinal Chemistry Traumatic Brain Injury: A Forensic Approach: A Literature Review
Current Neuropharmacology Dopamine Neurons in the Ventral Tegmental Area: Drug-induced Synaptic Plasticity and Its Role in Relapse to Drug-seeking Behavior
Current Drug Abuse Reviews Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
Current Pharmaceutical Design Conjugative Post-Translational Modifications for Pharmacological Improvement of Therapeutic Proteins
Current Proteomics Resveratrol and Stroke: from Chemistry to Medicine
Current Neurovascular Research